kadsurenone has been researched along with caffeic acid in 1 studies
| Studies (kadsurenone) | Trials (kadsurenone) | Recent Studies (post-2010) (kadsurenone) | Studies (caffeic acid) | Trials (caffeic acid) | Recent Studies (post-2010) (caffeic acid) |
|---|---|---|---|---|---|
| 51 | 0 | 3 | 2,074 | 15 | 1,187 |
| Protein | Taxonomy | kadsurenone (IC50) | caffeic acid (IC50) |
|---|---|---|---|
| RNA polymerase beta subunit (EC 2.7.7.6), partial | Escherichia coli | 23.7759 | |
| Lipoxygenase | Solanum tuberosum (potato) | 3.5 | |
| Interstitial collagenase | Homo sapiens (human) | 0.2389 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 3 | |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | 3 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 0.0243 | |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 8.5 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 0.0156 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 3.06 | |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | 3.37 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.1246 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 3 | |
| Integrase | Human immunodeficiency virus 1 | 2.8 | |
| large T antigen | Betapolyomavirus macacae | 7.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coy, ED; Cuca, LE; Sefkow, M | 1 |
1 other study(ies) available for kadsurenone and caffeic acid
| Article | Year |
|---|---|
COX, LOX and platelet aggregation inhibitory properties of Lauraceae neolignans.
Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Lauraceae; Lipoxygenase Inhibitors; Platelet Aggregation Inhibitors; Rabbits | 2009 |